Академический Документы
Профессиональный Документы
Культура Документы
uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
6 September 2016
wertyuiopasdfghjklzxcvbnmqwertyui
Prepared by: Meenakshi Pal
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
th
NIFTY FUTURE
NIFTY FUTURE :
PIVOT :8826
R1:8860
S1:8806
R2:8880
S2:8773
R3:8913
S3:8753
STRATEGY: Buy Nifty Future above 8850 for the target of 8900 -8950 with the stop loss of 8770.
SECTORAL INDICES
RESISTANCE 2 RESISTANCE 1
LTP
SUPPORT 1
SUPPORT 2
SENSEX
28800
28650
28532.11
28150
28000
NIFTY
8900
8850
8809.65
8740
8700
NIFTYBANK
20150
20000
19883.20
19750
19600
NIFTYIT
10700
10625
10528.35
10450
10400
CORPORATE NEWS
Tata Motors Passenger and Commercial Vehicle sales in August stood at 43,061 vehicles, a growth
of 6 percent, over 40,679 vehicles sales in August 2015. Domestic sales grew by 3% whereas exports
were up by 27%. JLR's US sales grew by 46% to 9,329 vehicles, driven largely by recently launched
F-PACE and XE.
Cadila Healthcares oral solid dosage drug facility, located at SEZ, Ahmedabad, received an
establishment inspection report (EIR) from the USFDA. This is the third EIR for the companys
establishment in the current quarter. Shares went up by 2.3%.
Bajaj Auto reported a 5% fall in total sales at 3,25,347 units in August 2016, as against 3,41,965 unit
sales in August 2015. Motorcycle sales decreased by 4% to 2,79,977 units from 2,90,436 units sold
previously. Commercial Vehicle reported a 12% decline. Also, exports went down by 31%.
WWW.EQUITYRESEARCHLAB.CO.IN
Designation
E-mail ID
Research Head
Sr. Research Analyst
Sr. Research Analyst
Tuhinanshu.jain@equityresearchlab.co.in
Yogesh.subnani@equityresearchlab.co.in
Meenakshi.pal@equityresearchlab.co.in
DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.
Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.
Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.
ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.CO.IN